{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:14:19Z","timestamp":1789902859592,"version":"4.0.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>It has been amply described that levels of IgM antibodies against <jats:italic>Mycobacterium leprae<\/jats:italic> (<jats:italic>M. leprae<\/jats:italic>) phenolic glycolipid I (PGL-I) correlate strongly with the bacterial load in an infected individual. These findings have generated the concept of using seropositivity for antibodies against <jats:italic>M. leprae<\/jats:italic> PGL-I as an indicator of the proportion of the population that has been infected. Although anti-PGL-I IgM levels provide information on whether an individual has ever been infected, their presence cannot discriminate between recent and past infections. Since infection in (young) children by definition indicates recent transmission, we piloted the feasibility of assessment of anti-PGL-I IgM seroprevalence among children in a leprosy endemic area in India as a proxy for recent <jats:italic>M. leprae<\/jats:italic> transmission.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>A serosurvey for anti-PGL-I IgM antibodies among children in highly leprosy endemic villages in Bihar, India, was performed, applying the quantitative anti-PGL-I UCP-LFA cassette combined with low-invasive, small-volume fingerstick blood (FSB).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Local staff obtained FSB of 1,857 children (age 3\u201311 years) living in 12 leprosy endemic villages in Bihar; of these, 215 children (11.58%) were seropositive for anti-PGL-I IgM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The anti-PGL-I seroprevalence level of 11.58% among children corresponds with the seroprevalence levels described in studies in other leprosy endemic areas over the past decades where no prophylactic interventions have taken place. The anti-PGL-I UCP-LFA was found to be a low-complexity tool that could be practically combined with serosurveys and was well-accepted by both healthcare staff and the population. On route to leprosy elimination, quantitative anti-PGL-I serology in young children holds promise as a strategy to monitor recent <jats:italic>M. leprae<\/jats:italic> transmission in an area.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1260375","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T06:04:46Z","timestamp":1695881086000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Field-friendly anti-PGL-I serosurvey in children to monitor Mycobacterium leprae transmission in Bihar, India"],"prefix":"10.3389","volume":"10","author":[{"given":"Louise","family":"Pierneef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paritosh","family":"Malaviya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"van Hooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Meuldijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awnish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristien","family":"Cloots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Corstjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Epco","family":"Hasker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Geluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13071-015-1143-4","article-title":"Global elimination of leprosy by 2020: are we on track?","volume":"20","author":"Blok","year":"2015","journal-title":"Trop Med Int Health."},{"key":"B2","unstructured":"Leprosy"},{"key":"B3","doi-asserted-by":"publisher","first-page":"698588","DOI":"10.3389\/fmicb.2021.698588","article-title":"Mycobacterium lepromatosis as a second agent of Hansen's disease","volume":"12","author":"Deps","year":"2021","journal-title":"Front Microbiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","article-title":"The continuing challenges of leprosy","volume":"19","author":"Scollard","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.smim.2018.06.003","article-title":"Correlates of immune exacerbations in leprosy","volume":"39","author":"Geluk","year":"2018","journal-title":"Semin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/oxfordjournals.aje.a009195","article-title":"Household and dwelling contact as risk factors for leprosy in northern Malawi","volume":"146","author":"Fine","year":"1997","journal-title":"Am J Epidemiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1093\/cid\/ciw570","article-title":"Molecular evidence for the aerial route of infection of Mycobacterium leprae and the role of asymptomatic carriers in the persistence of leprosy","volume":"63","author":"Araujo","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3389\/fmicb.2020.01220","article-title":"Genomic characterization of mycobacterium leprae to explore transmission patterns identifies new subtype in Bangladesh","volume":"11","author":"Tio-Coma","year":"2020","journal-title":"Front Microbiol."},{"key":"B9","year":"2022","journal-title":"Global leprosy (Hansen disease) update, 2021: moving towards interruption of transmission"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0003658","DOI":"10.1371\/journal.pntd.0003658","article-title":"The missing millions: a threat to the elimination of leprosy","volume":"9","author":"Smith","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1013","DOI":"10.1371\/journal.pntd.0001013","article-title":"Leprosy among patient contacts: a multilevel study of risk factors","volume":"5","author":"Sales","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.47276\/lr.85.1.2","article-title":"Role of contact tracing and prevention strategies in the interruption of leprosy transmission","volume":"85","author":"Smith","year":"2014","journal-title":"Leprosy Rev."},{"key":"B13","year":"2000","journal-title":"Leprosy Elimination Monitoring (LEM): Guidelines for monitors"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0009769","DOI":"10.1371\/journal.pntd.0009769","article-title":"Measuring endemicity and burden of leprosy across countries and regions: A systematic review and Delphi survey","volume":"15","author":"Ogunsumi","year":"2021","journal-title":"Plos Neglect Trop D."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e250835","DOI":"10.1136\/bcr-2022-250835","article-title":"Multibacillary leprosy with an incubation period exceeding 50 years","volume":"15","author":"Taggart","year":"2022","journal-title":"Bmj Case Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.47276\/lr.75.4.310","article-title":"Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions","volume":"75","author":"Moet","year":"2004","journal-title":"Leprosy Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0008687","DOI":"10.1371\/journal.pntd.0008687","article-title":"Patients with skin smear positive leprosy in Bangladesh are the main risk factor for leprosy development: 21-year follow-up in the household contact study (COCOA)","volume":"14","author":"Quilter","year":"2020","journal-title":"Plos Neglect Trop D"},{"key":"B18","doi-asserted-by":"publisher","first-page":"8868","DOI":"10.1038\/s41598-017-07803-7","article-title":"Field-friendly serological tests for determination of M. leprae-specific antibodies","volume":"7","author":"van Hooij","year":"2017","journal-title":"Sci Rep-Uk"},{"key":"B19","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1590\/S0100-879X2009001000016","article-title":"Use of anti-PGL-1 antibodies to monitor therapy regimes in leprosy patients","volume":"42","author":"Zenha","year":"2009","journal-title":"Braz J Med Biol Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0009667","DOI":"10.1371\/journal.pntd.0009667","article-title":"Detection of anti-M. leprae antibodies in children in leprosy-endemic areas: A systematic review","volume":"15","author":"Pierneef","year":"2021","journal-title":"Plos Neglect Trop D"},{"key":"B21","doi-asserted-by":"publisher","first-page":"963674","DOI":"10.3389\/fitd.2022.963674","article-title":"Detection of anti-M. leprae antibodies in healthy children in China: A systematic review of Chinese literature","volume":"3","author":"Zhou","year":"2022","journal-title":"Front Trop Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clinbiochem.2019.01.007","article-title":"Fingerstick test quantifying humoral and cellular biomarkers indicative for M-leprae infection","volume":"66","author":"Corstjens","year":"2019","journal-title":"Clin Biochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"17920","DOI":"10.1038\/s41598-018-36323-1","article-title":"Evaluation of Immunodiagnostic Tests for Leprosy in Brazil, China and Ethiopia","volume":"8","author":"van Hooij","year":"2018","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"102006","DOI":"10.1016\/j.isci.2020.102006","article-title":"Prototype multi-biomarker test for point-of-care leprosy diagnostics","volume":"24","author":"van Hooij","year":"2021","journal-title":"Iscience"},{"key":"B25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ebiom.2019.08.009","article-title":"Application of new host biomarker profiles in quantitative point-of-care tests facilitates leprosy diagnosis in the field","volume":"47","author":"van Hooij","year":"2019","journal-title":"Ebiomedicine."},{"key":"B26","doi-asserted-by":"publisher","first-page":"763289","DOI":"10.3389\/fmicb.2021.763289","article-title":"Detection and monitoring of Mycobacterium leprae infection in nine banded armadillos (Dasypus novemcinctus) using a quantitative rapid test","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Microbiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.clinbiochem.2007.12.015","article-title":"User-friendly, highly sensitive assay to detect the IFN-gamma secretion by T cells","volume":"41","author":"Corstjens","year":"2008","journal-title":"Clin Biochem."},{"key":"B28","year":"2022","journal-title":"The Global Health Observatory. Leprosy - New leprosy child case detection rate (less than 15 years of age) per 1,000,000 child population"},{"key":"B29","doi-asserted-by":"publisher","first-page":"7004","DOI":"10.1371\/journal.pntd.0007004","article-title":"Does appreciative inquiry decrease false positive diagnosis during leprosy case detection campaigns in Bihar, India? An operational research study","volume":"12","author":"Wagh","year":"2018","journal-title":"Plos Neglect Trop D"},{"key":"B30","volume-title":"Census of India 2011: Population Projections for India and States 2011\u20132036.","author":"Technical","year":"2019"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0007798","DOI":"10.1371\/journal.pntd.0007798","article-title":"Post kala azar dermal leishmaniasis and leprosy prevalence and distribution in the Muzaffarpur health and demographic surveillance site","volume":"13","author":"Hasker","year":"2019","journal-title":"Plos Neglect Trop D"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/ije\/dyu178","article-title":"Health & demographic surveillance system profile: the Muzaffarpur-TMRC health and demographic surveillance system","volume":"43","author":"Malaviya","year":"2014","journal-title":"Int J Epidemiol."},{"key":"B33","year":"2023","journal-title":"Bacillus Calmette-Gu\u00e9rin (BCG) vaccination coverage"},{"key":"B34","doi-asserted-by":"publisher","first-page":"E23","DOI":"10.1016\/S2666-5247(20)30166-X","article-title":"Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study","volume":"2","author":"Singh","year":"2021","journal-title":"Lancet Microbe."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/cbic.202000810","article-title":"Synthetic phenolic glycolipids for application in diagnostic tests for leprosy","volume":"22","author":"van Dijk","year":"2021","journal-title":"Chembiochem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0008254","DOI":"10.1371\/journal.pntd.0008254","article-title":"Kala-azar elimination in a highly-endemic district of Bihar, India: A success story","volume":"14","author":"Kumar","year":"2020","journal-title":"Plos Neglect Trop D"},{"key":"B37","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12879-015-1260-x","article-title":"Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review","volume":"15","author":"Trindade","year":"2015","journal-title":"BMC Infect Dis"},{"key":"B38","year":"1991","journal-title":"Leprosy Resolution WHA 44.9: Forty-fourth World Health Assembly"},{"key":"B39","first-page":"405","article-title":"IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy","volume":"59","author":"Ulrich","year":"1991","journal-title":"Int J Lepr Other Mycobact Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"8652062","DOI":"10.1155\/2022\/8652062","article-title":"Leprosy: a review of epidemiology, clinical diagnosis, and management","volume":"2022","author":"Chen","year":"2022","journal-title":"J Trop Med-Us."},{"key":"B41","doi-asserted-by":"publisher","first-page":"292","DOI":"10.47276\/lr.93.4.292","article-title":"Improving early case detection in leprosy: Reports from recent workshops","volume":"93","author":"Saunderson","year":"2022","journal-title":"Leprosy Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e0006083","DOI":"10.1371\/journal.pntd.0006083","article-title":"Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh","volume":"11","author":"Richardus","year":"2017","journal-title":"Plos Neglect Trop D"},{"key":"B43","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12879-018-3402-4","article-title":"An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP plus","volume":"18","author":"Mieras","year":"2018","journal-title":"BMC Infect Dis."},{"key":"B44","year":"2022","journal-title":"Factsheet on SDR-PEP: The latest research on single-dose rifampicin post-exposure prophylaxis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1016\/S2214-109X(19)30536-4","article-title":"Impact of the visceral leishmaniasis elimination initiative on Leishmania donovani transmission in Nepal: a 10-year repeat survey","volume":"8","author":"Cloots","year":"2020","journal-title":"Lancet Glob Health."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1260375\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T06:04:50Z","timestamp":1695881090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1260375\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":45,"alternative-id":["10.3389\/fmed.2023.1260375"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1260375","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]},"article-number":"1260375"}}